Patient perceptions of stool DNA testing for pan-digestive cancer screening: A survey questionnaire

World Journal of Gastroenterology

Volumn 20, Issue 17, 2014, Pages 4972-4979

  Yang, Dennis ^a   Hillman, Shauna L ^a   Harris, Ann M ^a   Sinicrope, Pamela S ^a   Devens, Mary E ^a   Ahlquist, David A ^a  

^a MAYO CLINIC   (United States)

Author keywords

Colorectal cancer screening; Gastrointestinal cancer screening; Patient perceptions; Stool DNA testing

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SCREENING; COLORECTAL CANCER; DNA DETERMINATION; EXPLORATORY RESEARCH; FECES ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PATIENT ATTITUDE; PATIENT PREFERENCE; QUESTIONNAIRE; ATTITUDE TO HEALTH; CHEMISTRY; DIGESTIVE SYSTEM NEOPLASMS; EARLY DIAGNOSIS; FECES; FEMALE; GENETIC SCREENING; GENETICS; HEALTH CARE SURVEY; PATIENT; PERCEPTION; PREDICTIVE VALUE; PROCEDURES; PSYCHOLOGY; REGISTER; UNITED STATES;

DNA; TUMOR MARKER;

AGED; DIGESTIVE SYSTEM NEOPLASMS; DNA, NEOPLASM; EARLY DETECTION OF CANCER; FECES; FEMALE; GENETIC TESTING; HEALTH CARE SURVEYS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; MINNESOTA; PATIENT PREFERENCE; PATIENTS; PERCEPTION; PREDICTIVE VALUE OF TESTS; QUESTIONNAIRES; REGISTRIES; TUMOR MARKERS, BIOLOGICAL;

EID: 84899825578     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i17.4972     Document Type: Article

References (35)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013; 63: 11-30 [PMID: 23335087 DOI: 10.3322/ caac.21166]
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90 [PMID: 21296855 DOI: 10.3322/caac.20107]
3. Zou H, Harrington JJ, Taylor WR, Devens ME, Cao X, Heigh RI, Romero Y, Chari ST, Petersen GM, Roberts LR, Kasperbauer J, Hussain FT, Simonson JA, Smith DI, Ahlquist DA. T2036 Pan-Detection of Gastrointestinal Neoplasms By Stool DNA Testing: Establishment of Feasibility. Gastroenterology 2009; 136: Abstract T2036 [DOI: 10.1016/S0016-5085(09)62882-1]
4. Kisiel JB, Yab TC, Taylor WR, Chari ST, Petersen GM, Mahoney DW, Ahlquist DA. Stool DNA testing for the detection of pancreatic cancer: assessment of methylation marker candidates. Cancer 2012; 118: 2623-2631 [PMID: 22083596 DOI: 10.1002/cncr/26558]
5. Nagasaka T, Tanaka N, Cullings HM, Sun DS, Sasamoto H, Uchida T, Koi M, Nishida N, Naomoto Y, Boland CR, Matsubara N, Goel A. Analysis of fecal DNA methylation to detect gastrointestinal neoplasia. J Natl Cancer Inst 2009; 101: 1244-1258 [PMID: 19700653 DOI: 10.1093/jnci/djp265]
6. Levin B, Lieberman DA, McFarland B, Andrews KS, Brooks D, Bond J, Dash C, Giardiello FM, Glick S, Johnson D, Johnson CD, Levin TR, Pickhardt PJ, Rex DK, Smith RA, Thorson A, Winawer SJ. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008; 134: 1570-1595 [PMID: 18384785 DOI: 10.1053/ j.gastro.2008.02.002]
7. Weitzman ER, Zapka J, Estabrook B, Goins KV. Risk and reluctance: understanding impediments to colorectal cancer screening. Prev Med 2001; 32: 502-513 [PMID: 11394954 DOI: 10.1006/pmed.2001.0838]
8. Gluecker TM, Johnson CD, Harmsen WS, Offord KP, Harris AM, Wilson LA, Ahlquist DA. Colorectal cancer screening with CT colonography, colonoscopy, and double-contrast barium enema examination: prospective assessment of patient perceptions and preferences. Radiology 2003; 227: 378-384 [PMID: 12732696 DOI: 10.1148/radiol.2272020293]
9. Schroy PC, Heeren TC. Patient perceptions of stool-based DNA testing for colorectal cancer screening. Am J Prev Med 2005; 28: 208-214 [PMID: 15710277 DOI: 10.1016/ j.amepre.2004/10.008]
10. Allison JE, Tekawa IS, Ransom LJ, Adrain AL. A comparison of fecal occult-blood tests for colorectal-cancer screening. N Engl J Med 1996; 334: 155-159 [PMID: 8531970 DOI: 10.1056/NEJM199601183340304]
11. Ahlquist DA, McGill DB, Fleming JL, Schwartz S, Wieand HS, Rubin J, Moertel CG. Patterns of occult bleeding in asymptomatic colorectal cancer. Cancer 1989; 63: 1826-1830 [PMID: 2702590]
12. Imperiale TF, Ransohoff DF, Itzkowitz SH, Turnbull BA, Ross ME. Fecal DNA versus fecal occult blood for colorectalcancer screening in an average-risk population. N Engl J Med 2004; 351: 2704-2714 [PMID: 15616205 DOI: 10.1056/NEJMoa033403]
13. Ahlquist DA. Next-generation stool DNA testing: expanding the scope. Gastroenterology 2009; 136: 2068-2073 [PMID: 19379748 DOI: 10.1053/j.gastro.2009.04.025]
14. Berger BM, Ahlquist DA. Stool DNA screening for colorectal neoplasia: biological and technical basis for high detection rates. Pathology 2012; 44: 80-88 [PMID: 22198259 DOI: 10.1097/PAT.0b013e3283502fdf]
15. Ahlquist DA, Zou H, Domanico M, Mahoney DW, Yab TC, Taylor WR, Butz ML, Thibodeau SN, Rabeneck L, Paszat LF, Kinzler KW, Vogelstein B, Bjerregaard NC, Laurberg S, Sørensen HT, Berger BM, Lidgard GP. Next-generation stool DNA test accurately detects colorectal cancer and large adenomas. Gastroenterology 2012; 142: 248-256; quiz e25-26 [PMID: 22062357 DOI: 10.1053/j.gastro.2011.10.031]
16. Lidgard GP, Domanico MJ, Bruinsma JJ, Light J, Gagrat ZD, Oldham-Haltom RL, Fourrier KD, Allawi H, Yab TC, Taylor WR, Simonson JA, Devens M, Heigh RI, Ahlquist DA, Berger BM. Clinical performance of an automated stool DNA assay for detection of colorectal neoplasia. Clin Gastroenterol Hepatol 2013; 11: 1313-1318 [PMID: 23639600 DOI: 10.1016/ j.cgh.2013.04.023]
17. Exact Sciences Corporation. Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer (DeeP-C). In Clinical Trials. gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2013. Available from: URL: http://clinicaltrials.gov/ ct2/show/NCT01397747
18. Wolf RL, Basch CE, Brouse CH, Shmukler C, Shea S. Patient preferences and adherence to colorectal cancer screening in an urban population. Am J Public Health 2006; 96: 809-811 [PMID: 16571715 DOI: 10.2105/AJPH/2004/049684]
19. Marshall DA, Johnson FR, Phillips KA, Marshall JK, Thabane L, Kulin NA. Measuring patient preferences for colorectal cancer screening using a choice-format survey. Value Health 2007; 10: 415-430 [PMID: 17888107 DOI: 10.1111/ j.1524-4733.2007.00196.x]
20. Osborn NK, Ahlquist DA. Stool screening for colorectal cancer: molecular approaches. Gastroenterology 2005; 128: 192-206 [PMID: 15633136 DOI: 10.1053/j.gastro.2004/10.041]
21. Schroy PC, Lal S, Glick JT, Robinson PA, Zamor P, Heeren TC. Patient preferences for colorectal cancer screening: how does stool DNA testing fare? Am J Manag Care 2007; 13: 393-400 [PMID: 17620034]
22. Meissner HI, Breen N, Klabunde CN, Vernon SW. Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomarkers Prev 2006; 15: 389-394 [PMID: 16492934 DOI: 10.1158/1055-9965. EPI-05-0678]
23. Subramanian S, Klosterman M, Amonkar MM, Hunt TL. Adherence with colorectal cancer screening guidelines: a review. Prev Med 2004; 38: 536-550 [PMID: 15066356 DOI: 10.1016/j.ypmed.2003.12.011]
24. Gorin SS. Correlates of colorectal cancer screening compliance among urban Hispanics. J Behav Med 2005; 28: 125-137 [PMID: 15957568 DOI: 10.1007/s10865-005-3662-5]
25. Hawley ST, Volk RJ, Krishnamurthy P, Jibaja-Weiss M, Ver-non SW, Kneuper S. Preferences for colorectal cancer screening among racially/ethnically diverse primary care patients. Med Care 2008; 46: S10-S16 [PMID: 18725820 DOI: 10.1097/ MLR/0b013e31817d932e]
26. Klabunde CN, Vernon SW, Nadel MR, Breen N, Seeff LC, Brown ML. Barriers to colorectal cancer screening: a comparison of reports from primary care physicians and averagerisk adults. Med Care 2005; 43: 939-944 [PMID: 16116360 DOI: 10.1097/01.mlr.0000173599.67470.ba]
27. Brouse CH, Basch CE, Wolf RL, Shmukler C, Neugut AI, Shea S. Barriers to colorectal cancer screening with fecal occult blood testing in a predominantly minority urban population: a qualitative study. Am J Public Health 2003; 93: 1268-1271 [PMID: 12893609 DOI: 10.2105/AJPH.93.8.1268]
28. Lasser KE, Ayanian JZ, Fletcher RH, Good MJ. Barriers to colorectal cancer screening in community health centers: a qualitative study. BMC Fam Pract 2008; 9: 15 [PMID: 18304342 DOI: 10.1186/1471-2296-9-15]
29. Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, Snover DC, Schuman LM. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000; 343: 1603-1607 [PMID: 11096167 DOI: 10.1056/NEJM200011303432203]
30. Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, James PD, Mangham CM. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996; 348: 1472-1477 [PMID: 8942775 DOI: 10.1016/S0140-6736(96)03386-7]
31. Smith RA, Cokkinides V, Eyre HJ. Cancer screening in the United States, 2007: a review of current guidelines, practices, and prospects. CA Cancer J Clin 2007; 57: 90-104 [PMID: 17392386 DOI: 10.3322/canjclin.57.2.90]
32. Heresbach D, Manfredi S, D'halluin PN, Bretagne JF, Branger B. Review in depth and meta-analysis of controlled trials on colorectal cancer screening by faecal occult blood test. Eur J Gastroenterol Hepatol 2006; 18: 427-433 [PMID: 16538116 DOI: 10.1097/00042737-200604000-00018]
33. Seeff LC, Nadel MR, Klabunde CN, Thompson T, Shapiro JA, Vernon SW, Coates RJ. Patterns and predictors of colorectal cancer test use in the adult U.S. population. Cancer 2004; 100: 2093-2103 [PMID: 15139050 DOI: 10.1002/cncr.20276]
34. Denberg TD, Melhado TV, Coombes JM, Beaty BL, Berman K, Byers TE, Marcus AC, Steiner JF, Ahnen DJ. Predictors of nonadherence to screening colonoscopy. J Gen Intern Med 2005; 20: 989-995 [PMID: 16307622 DOI: 10.1111/ j.1525-1497.2005.00164]
35. Harewood GC, Wiersema MJ, Melton LJ. A prospective, controlled assessment of factors influencing acceptance of screening colonoscopy. Am J Gastroenterol 2002; 97: 3186-3194 [PMID: 12492209 DOI: 10.106/S0002-9270(02)05546-6]